 Anthem Inc NYSE: ANTM has reported Q4 adjusted EPS of 5.14, more than double from 2.54 a year ago and beating the consensus of 5.11. Operating revenue rose 14.2 to 36 billion, slightly missing expectations of 36.51 billion, driven by higher premium revenue due to growth in Medicaid and Medicare and pharmacy product revenue related to IngenioRx. 